National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)
National Institutes of Health
Classification and identifiers
- Solicitation number
- PAR-27-105
- Assistance listing (CFDA)
- 93.286
Amount
Amount not published by the funder
Who can apply
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Foreign InstitutionsNon-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.Number of ApplicationsApplicant organizations may submit more than one application, provided that each application is scientifically distinct.NIH will not accept duplicate or highly overlapping applications under review at the same time per NIH Grants Policy Statement Section 2.3.7.4 Submissio...
About this opportunity
This Notice of Funding Opportunity (NOFO) encourages grant applications for National Centers for Biomedical Imaging and Bioengineering (NCBIB). NCBIB are national resource centers for conducting research and development on new technologies that are driven by the needs of basic, translational, and/or clinical researchers. NCBIB also make their technologies available to other investigators, train members of the research community in the use of the technologies and disseminate the technologies broadly.
Related opportunities
- National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)National Institutes of HealthCloses in 63 days
- National Biomedical Research Centers (P50 Clinical Trial Optional)National Institutes of HealthUp to $11.4M
- Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)National Institutes of HealthCloses Jan 2028
- Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)National Institutes of HealthCloses Jan 2028
- Funding Opportunity Announcement - NIBIB Technology Development NetworksNational Institutes of HealthUp to $1.0M
- Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)National Institutes of Health